Global Cholera Vaccine Market Research Report 2025(Status and Outlook)
Description
Report Overview
The cholera vaccine is a preventive biological product designed to stimulate immunity against Vibrio cholerae, the bacterium responsible for cholera, a severe diarrheal disease transmitted through contaminated water or food. Marketed in both oral and injectable forms, these vaccines are primarily utilized in endemic regions, outbreak responses, and by travelers to high-risk areas. The global cholera vaccine market is driven by increasing cholera outbreaks in developing countries with poor sanitation, government-led immunization programs, and support from international health organizations like WHO and Gavi. However, challenges such as limited vaccine accessibility in remote regions, cold chain storage requirements, and competition from alternative public health measures (e.g., improved water sanitation) constrain market growth. Key players include Sanofi, Valneva, and emerging manufacturers in India and South Korea, with demand concentrated in Sub-Saharan Africa, South Asia, and Haiti. Innovations in thermostable vaccines and cost-effective production methods are expected to shape future market expansion.
The global Cholera Vaccine market size was estimated at USD 94.35 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.89% during the forecast period.
This report provides a deep insight into the global Cholera Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cholera Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cholera Vaccine market in any manner.
Global Cholera Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia
Sanofi
...
Market Segmentation (by Type)
Dukoral
Shanchol
Vaxchora
Others
Market Segmentation (by Application)
Hospital
Scientific Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cholera Vaccine Market
Overview of the regional outlook of the Cholera Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cholera Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cholera Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The cholera vaccine is a preventive biological product designed to stimulate immunity against Vibrio cholerae, the bacterium responsible for cholera, a severe diarrheal disease transmitted through contaminated water or food. Marketed in both oral and injectable forms, these vaccines are primarily utilized in endemic regions, outbreak responses, and by travelers to high-risk areas. The global cholera vaccine market is driven by increasing cholera outbreaks in developing countries with poor sanitation, government-led immunization programs, and support from international health organizations like WHO and Gavi. However, challenges such as limited vaccine accessibility in remote regions, cold chain storage requirements, and competition from alternative public health measures (e.g., improved water sanitation) constrain market growth. Key players include Sanofi, Valneva, and emerging manufacturers in India and South Korea, with demand concentrated in Sub-Saharan Africa, South Asia, and Haiti. Innovations in thermostable vaccines and cost-effective production methods are expected to shape future market expansion.
The global Cholera Vaccine market size was estimated at USD 94.35 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.89% during the forecast period.
This report provides a deep insight into the global Cholera Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cholera Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cholera Vaccine market in any manner.
Global Cholera Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia
Sanofi
...
Market Segmentation (by Type)
Dukoral
Shanchol
Vaxchora
Others
Market Segmentation (by Application)
Hospital
Scientific Research
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cholera Vaccine Market
Overview of the regional outlook of the Cholera Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cholera Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cholera Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
134 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Cholera Vaccine
- 1.2 Key Market Segments
- 1.2.1 Cholera Vaccine Segment By Type
- 1.2.2 Cholera Vaccine Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Cholera Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Cholera Vaccine Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Cholera Vaccine Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Cholera Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Cholera Vaccine Product Life Cycle
- 3.3 Global Cholera Vaccine Sales By Manufacturers (2020-2025)
- 3.4 Global Cholera Vaccine Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Cholera Vaccine Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Cholera Vaccine Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Cholera Vaccine Market Competitive Situation And Trends
- 3.8.1 Cholera Vaccine Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Cholera Vaccine Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Cholera Vaccine Industry Chain Analysis
- 4.1 Cholera Vaccine Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Cholera Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Cholera Vaccine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Cholera Vaccine Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Cholera Vaccine Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Cholera Vaccine Sales Market Share By Type (2020-2025)
- 6.3 Global Cholera Vaccine Market Size Market Share By Type (2020-2025)
- 6.4 Global Cholera Vaccine Price By Type (2020-2025)
- 7 Cholera Vaccine Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Cholera Vaccine Market Sales By Application (2020-2025)
- 7.3 Global Cholera Vaccine Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Cholera Vaccine Sales Growth Rate By Application (2020-2025)
- 8 Cholera Vaccine Market Sales By Region
- 8.1 Global Cholera Vaccine Sales By Region
- 8.1.1 Global Cholera Vaccine Sales By Region
- 8.1.2 Global Cholera Vaccine Sales Market Share By Region
- 8.2 Global Cholera Vaccine Market Size By Region
- 8.2.1 Global Cholera Vaccine Market Size By Region
- 8.2.2 Global Cholera Vaccine Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Cholera Vaccine Sales By Country
- 8.3.2 North America Cholera Vaccine Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Cholera Vaccine Sales By Country
- 8.4.2 Europe Cholera Vaccine Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Cholera Vaccine Sales By Region
- 8.5.2 Asia Pacific Cholera Vaccine Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Cholera Vaccine Sales By Country
- 8.6.2 South America Cholera Vaccine Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Cholera Vaccine Sales By Region
- 8.7.2 Middle East And Africa Cholera Vaccine Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Cholera Vaccine Market Production By Region
- 9.1 Global Production Of Cholera Vaccine By Region(2020-2025)
- 9.2 Global Cholera Vaccine Revenue Market Share By Region (2020-2025)
- 9.3 Global Cholera Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Cholera Vaccine Production
- 9.4.1 North America Cholera Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Cholera Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Cholera Vaccine Production
- 9.5.1 Europe Cholera Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Cholera Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Cholera Vaccine Production (2020-2025)
- 9.6.1 Japan Cholera Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Cholera Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Cholera Vaccine Production (2020-2025)
- 9.7.1 China Cholera Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Cholera Vaccine Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Valneva
- 10.1.1 Valneva Basic Information
- 10.1.2 Valneva Cholera Vaccine Product Overview
- 10.1.3 Valneva Cholera Vaccine Product Market Performance
- 10.1.4 Valneva Business Overview
- 10.1.5 Valneva Swot Analysis
- 10.1.6 Valneva Recent Developments
- 10.2 Paxvax
- 10.2.1 Paxvax Basic Information
- 10.2.2 Paxvax Cholera Vaccine Product Overview
- 10.2.3 Paxvax Cholera Vaccine Product Market Performance
- 10.2.4 Paxvax Business Overview
- 10.2.5 Paxvax Swot Analysis
- 10.2.6 Paxvax Recent Developments
- 10.3 Shantha Biotechnics Limited
- 10.3.1 Shantha Biotechnics Limited Basic Information
- 10.3.2 Shantha Biotechnics Limited Cholera Vaccine Product Overview
- 10.3.3 Shantha Biotechnics Limited Cholera Vaccine Product Market Performance
- 10.3.4 Shantha Biotechnics Limited Business Overview
- 10.3.5 Shantha Biotechnics Limited Swot Analysis
- 10.3.6 Shantha Biotechnics Limited Recent Developments
- 10.4 Celldex Therapeutics
- 10.4.1 Celldex Therapeutics Basic Information
- 10.4.2 Celldex Therapeutics Cholera Vaccine Product Overview
- 10.4.3 Celldex Therapeutics Cholera Vaccine Product Market Performance
- 10.4.4 Celldex Therapeutics Business Overview
- 10.4.5 Celldex Therapeutics Recent Developments
- 10.5 Merck
- 10.5.1 Merck Basic Information
- 10.5.2 Merck Cholera Vaccine Product Overview
- 10.5.3 Merck Cholera Vaccine Product Market Performance
- 10.5.4 Merck Business Overview
- 10.5.5 Merck Recent Developments
- 10.6 Ceva Asia
- 10.6.1 Ceva Asia Basic Information
- 10.6.2 Ceva Asia Cholera Vaccine Product Overview
- 10.6.3 Ceva Asia Cholera Vaccine Product Market Performance
- 10.6.4 Ceva Asia Business Overview
- 10.6.5 Ceva Asia Recent Developments
- 10.7 Sanofi
- 10.7.1 Sanofi Basic Information
- 10.7.2 Sanofi Cholera Vaccine Product Overview
- 10.7.3 Sanofi Cholera Vaccine Product Market Performance
- 10.7.4 Sanofi Business Overview
- 10.7.5 Sanofi Recent Developments
- 10.8 ...
- 10.8.1 ... Basic Information
- 10.8.2 ... Cholera Vaccine Product Overview
- 10.8.3 ... Cholera Vaccine Product Market Performance
- 10.8.4 ... Business Overview
- 10.8.5 ... Recent Developments
- 11 Cholera Vaccine Market Forecast By Region
- 11.1 Global Cholera Vaccine Market Size Forecast
- 11.2 Global Cholera Vaccine Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Cholera Vaccine Market Size Forecast By Country
- 11.2.3 Asia Pacific Cholera Vaccine Market Size Forecast By Region
- 11.2.4 South America Cholera Vaccine Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Cholera Vaccine By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Cholera Vaccine Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Cholera Vaccine By Type (2026-2033)
- 12.1.2 Global Cholera Vaccine Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Cholera Vaccine By Type (2026-2033)
- 12.2 Global Cholera Vaccine Market Forecast By Application (2026-2033)
- 12.2.1 Global Cholera Vaccine Sales (K Mt) Forecast By Application
- 12.2.2 Global Cholera Vaccine Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.